The chart below shows how GENI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, GENI sees a -0.06% change in stock price 10 days leading up to the earnings, and a +0.14% change 10 days following the report. On the earnings day itself, the stock moves by +0.47%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Group Revenue Increase: We delivered group revenue of $120 million, representing an 18% year-on-year growth.
EBITDA Margin Improvement: This revenue growth contributed to our group adjusted EBITDA at a 43% incremental margin, as a result of our largely fixed cost base and disciplined control of operating expenses.
EBITDA Growth and Margin Expansion: This translated to group adjusted EBITDA of $26 million in the quarter representing 45% growth year-on-year and 400 basis points of margin expansion to 21%.
EBITDA Margin Expansion: Our consistent group adjusted EBITDA margin expansion over the last few years should demonstrate the operating leverage of our business model.
2024 Revenue and EBITDA Guidance: We are raising our 2024 guidance and expect to finish the year with $511 million in group revenue, up 24% year-on-year, and $86 million in group adjusted EBITDA up 61%, both significantly above our initial guidance of $480 million and $75 million respectively.
Negative
Revenue Growth Analysis: Group revenue of $120 million represented an 18% year-on-year growth, which is lower than expected.
EBITDA Margin Expansion: The adjusted EBITDA margin expanded to 21%, indicating a 400 basis points increase, but still below the target of 30%.
High Operating Expenses Impact Income: Operating expenses remained high, leading to a decrease in net income compared to previous quarters.
Stagnant Customer Growth: Customer growth was stagnant, with no significant increase in new accounts during the quarter.
Product Development Delays: The company faced challenges in product development, resulting in delays in launching new features that were anticipated for this quarter.
Genius Sports Limited (GENI) Q3 2024 Earnings Call Transcript
GENI.N
-4.51%